Bruno Miguel Neves

Prof. Bruno Miguel Neves

Department of Medical Sciences and Institute of Biomedicine – iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2017 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
JCJoão Constantino
João Constantino
Célia GomesCélia Gomes
Célia Gomes
AFAmílcar Falcão
Amílcar Falcão
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves
Maria Teresa CruzMaria Teresa Cruz
Maria Teresa Cruz

1 February 2016 in Translational Research
Verified
Journal Article
Closed access
JCJoão Constantino
João Constantino
Célia GomesCélia Gomes
Célia Gomes
AFAmílcar Falcão
Amílcar Falcão
Maria Teresa CruzMaria Teresa Cruz
Maria Teresa Cruz
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves

23 June 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Tiago CondeTiago Conde
Tiago Conde
BNBruna Neves
Bruna Neves
DCDaniela Couto
Daniela Couto
TMTânia Melo
Tânia Melo
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves
MDM Rosario Domingues
M Rosario Domingues
The demand for sustainable and environmentally friendly food sources and food ingredients is increasing, and microalgae are promoted as a sustainable source of essential and bioactive lipids, with high levels of omega-3 fatty acids (ω-3 FA), comparable to those of fish. However, most FA screening studies on algae are scattered or use different methodologies, preventing a true comparison of its content between microalgae. In this work, we used gas-chromatography mass-spectrometry (GC-MS) to characterize the FA profile of seven different commercial microalgae with biotechnological applications (Chlorella vulgaris, Chlorococcum amblystomatis, Scenedesmus obliquus, Tetraselmis chui, Phaeodactylum tricornutum, Spirulina sp., and Nannochloropsis oceanica). Screening for antioxidant activity was also performed to understand the relationship between FA profile and bioactivity. Microalgae exhibited specific FA profiles with a different composition, namely in the ω-3 FA profile, but with species of the same phylum showing similar tendencies. The different lipid extracts showed similar antioxidant activities, but with a low activity of the extracts of Nannochloropsis oceanica. Overall, this study provides a direct comparison of FA profiles between microalgae species, supporting the role of these species as alternative, sustainable, and healthy sources of essential lipids.


15 February 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
João CalmeiroJoão Calmeiro
João Calmeiro
Mylène CarrascalMylène Carrascal
Mylène Carrascal
Adriana TavaresAdriana Tavares
Adriana Tavares
DFDaniel Alexandre Ferreira
Daniel Alexandre Ferreira
Célia GomesCélia Gomes
Célia Gomes
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves
Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to be a safe therapeutic approach, although with inconsistent clinical results. The functional limitations of ex vivo monocyte-derived dendritic cells (MoDCs) commonly used in these therapies are one of the pointed explanations for their lack of robustness. Therefore, a great effort has been made to identify DC subsets with superior features for the establishment of effective anti-tumor responses and to apply them in therapeutic approaches. Among characterized human DC subpopulations, conventional type 1 DCs (cDC1) have emerged as a highly desirable tool for empowering anti-tumor immunity. This DC subset excels in its capacity to prime antigen-specific cytotoxic T cells and to activate natural killer (NK) and natural killer T (NKT) cells, which are critical factors for an effective anti-tumor immune response. Here, we sought to revise the immunobiology of cDC1 from their ontogeny to their development, regulation and heterogeneity. We also address the role of this functionally thrilling DC subset in anti-tumor immune responses and the most recent efforts to apply it in cancer immunotherapy.

1 March 2015 in Algal Research
Verified
Journal Article
Closed access
TMTânia Melo
Tânia Melo
EAEliana Alves
Eliana Alves
VAVítor Azevedo
Vítor Azevedo
AMAna Sofia Martins
Ana Sofia Martins
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves
MDM Rosario Domingues
M Rosario Domingues